Empirical Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.27M Buy
48,777
+3,608
+8% +$422K 0.09% 135
2026
Q1
$5.43M Buy
45,169
+7,239
+19% +$836K 0.09% 140
2025
Q4
$3.99M Buy
37,930
+9,826
+35% +$922K 0.07% 165
2025
Q3
$2.36M Sell
28,104
-1,390
-5% -$114K 0.05% 223
2025
Q2
$2.33M Sell
29,494
-4,811
-14% -$382K 0.05% 215
2025
Q1
$3.08M Sell
34,305
-2,908
-8% -$272K 0.08% 169
2024
Q4
$3.7M Buy
37,213
+2,660
+8% +$274K 0.1% 136
2024
Q3
$3.92M Buy
34,553
+3,250
+10% +$386K 0.11% 135
2024
Q2
$3.88M Buy
31,303
+9,853
+46% +$1.27M 0.11% 128
2024
Q1
$2.83M Sell
21,450
-570
-3% -$70.3K 0.09% 143
2023
Q4
$2.4M Sell
22,020
-258
-1% -$26.8K 0.08% 151
2023
Q3
$2.29M Buy
22,278
+4,523
+25% +$488K 0.09% 147
2023
Q2
$2.05M Buy
17,755
+1,008
+6% +$114K 0.08% 154
2023
Q1
$1.78M Buy
16,747
+483
+3% +$52.1K 0.08% 154
2022
Q4
$1.8M Buy
16,264
+646
+4% +$66K 0.09% 146
2022
Q3
$1.34M Buy
15,618
+528
+3% +$47.1K 0.07% 167
2022
Q2
$1.38M Buy
15,090
+2,952
+24% +$262K 0.07% 171
2022
Q1
$996K Sell
12,138
-2,499
-17% -$197K 0.05% 214
2021
Q4
$1.12M Buy
14,637
+1,419
+11% +$113K 0.06% 191
2021
Q3
$993K Sell
13,218
-1,639
-11% -$125K 0.06% 193
2021
Q2
$1.16M Buy
14,857
+522
+4% +$38.8K 0.07% 170
2021
Q1
$1.05M Buy
14,335
+3,625
+34% +$267K 0.08% 151
2020
Q4
$836K Sell
10,710
-20,631
-66% -$1.58M 0.06% 173
2020
Q3
$2.48M Sell
31,341
-5,168
-14% -$405K 0.21% 67
2020
Q2
$2.69M Buy
36,509
+1,016
+3% +$76.5K 0.25% 61
2020
Q1
$2.61M Buy
35,493
+4,375
+14% +$344K 0.28% 54
2019
Q4
$2.7M Buy
31,118
+3,819
+14% +$314K 0.3% 52
2019
Q3
$2.19M Sell
27,299
-1,689
-6% -$135K 0.27% 61
2019
Q2
$2.32M Buy
28,988
+887
+3% +$67.9K 0.3% 51
2019
Q1
$2.23M Buy
28,101
+17,754
+172% +$1.33M 0.32% 46
2018
Q4
$754K Sell
10,347
-62
-0.6% -$4.38K 0.13% 94
2018
Q3
$705K Buy
10,409
+3,543
+52% +$226K 0.13% 94
2018
Q2
$398K Buy
6,866
+1,233
+22% +$69.6K 0.07% 124
2018
Q1
$293K Buy
5,633
+818
+17% +$44.2K 0.06% 137
2017
Q4
$258K Buy
4,815
+288
+6% +$16K 0.06% 126
2017
Q3
$277K Buy
4,527
+102
+2% +$6.18K 0.06% 112
2017
Q2
$271K Buy
4,425
+416
+10% +$25.3K 0.07% 113
2017
Q1
$243K Buy
+4,009
New +$243K 0.06% 114
2016
Q1
Sell
-4,519
Closed -$228K 108
2015
Q4
$228K Sell
4,519
-1,963
-30% -$99K 0.06% 97
2015
Q3
$305K Sell
6,482
-20
-0.3% -$1.06K 0.07% 92
2015
Q2
$353K Buy
6,502
+2,319
+55% +$130K 0.08% 91
2015
Q1
$229K Buy
+4,183
New +$237K 0.05% 94
2014
Q4
Sell
-3,737
Closed -$211K 102
2014
Q3
$211K Buy
+3,737
New +$210K 0.05% 100
2014
Q2
Sell
-4,017
Closed -$218K 103
2014
Q1
$218K Buy
+4,017
New +$208K 0.06% 93

Other funds holding MRK

Empirical Wealth Management's MRK Position: Q2 2026 in Review

Empirical Wealth Management increased its Merck (MRK) stake by 8% in Q2 2026, buying an estimated $422K and bringing the position to 48,777 shares worth $6.27M. The position accounts for 0.09% of the portfolio, ranked #135.

Empirical Wealth Management first reported a position in MRK in Q1 2014 and has held it in 44 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Empirical Wealth Management held 48,777 shares of Merck worth $6.27M as of Q2 2026.
  • Empirical Wealth Management bought 3,608 Merck shares in Q2 2026, an estimated $422K.
  • Merck made up 0.09% of Empirical Wealth Management's portfolio in Q2 2026, its #135 holding.
  • Empirical Wealth Management first reported a position in Merck in Q1 2014 and has held it in 44 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.